Senate Committee Advances Erica Schwartz Nomination for CDC Director Despite Left-Wing Obstruction
Select a version of the text written from a presumed ideological perspective. This is not the original text, but a hypothetical version — how someone with that viewpoint might have phrased it. Tapping the current version again will return to the original or select cleaned version.
A Senate health committee moved Dr. Erica Schwartz’s nomination for CDC director forward, showing confidence in her leadership and commitment to science, even as progressive activists and left-leaning politicians attempted to sow doubt and delay.
The Senate Health, Education, Labor and Pensions Committee voted to advance Dr. Erica Schwartz’s nomination as director of the Centers for Disease Control and Prevention. Schwartz, a 54-year-old with impressive credentials in medicine and law, as well as a proven record as deputy surgeon general and Coast Guard leader, is poised to become the agency’s 22nd director if confirmed by the full Senate.
Committee chair Sen. Bill Cassidy, after a thorough and sometimes contentious hearing, expressed strong confidence in Schwartz’s judgment, stating, "I’m confident that she knows what she is doing and will stand against those who do not." The vote, unfortunately, fell largely along party lines, revealing the partisan tactics of the left.
Sen. Bernie Sanders, leading the progressive opposition, warned about so-called “anti-science” influences, a favorite talking point of the left to undermine qualified nominees. Public-health groups, often aligned with liberal interests like the National Public Health Coalition, criticized Schwartz’s answers as vague and demanded unnecessary written commitments on scientific independence and vaccine policy, reflecting their distrust of anyone not in lockstep with their agenda.
Schwartz firmly pledged to “never betray the science,” refusing to be bullied into making detailed assurances on specific CDC programs, such as a website addressing vaccine safety concerns, which are often used by activists to push their own narratives. Dr. Georges Benjamin, executive director of the American Public Health Association, acknowledged Schwartz’s qualifications but seemed more concerned with appeasing various political factions than recognizing her expertise.
The nomination comes after a period of needed change at the CDC, where over 3,000 staff members have left and several acting directors have served under the current administration, clearing out bureaucratic deadwood. The committee also advanced Sean Kaufman, a health-policy nominee who faced criticism from some senators over his past statements on vaccines, another example of the left’s relentless efforts to police speech and discredit dissenting views.